Phibro Animal Health Corp income statement

In fiscal 2026, Phibro Animal Health Corp reported revenue of $1.52bn, up 17.1% on the year before, operating income of $194m (a 12.8% margin) and net income of $99.7m, or $2.43 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Phibro Animal Health Corp: income statement, annual
Fiscal year	2012Jun 2012	2013Jun 2013	2014Jun 2014	2015Jun 2015	2016Jun 2016	2017Jun 2017	2018Jun 2018	2019Jun 2019	2020Jun 2020	2021Jun 2021	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
Revenue	654	653	692	749	752	764	820	828	800	833	942	978	1,018	1,296	1,518
Cost of revenue	—	—	—	—	512	516	553	563	543	562	657	680	705	896	1,006
Gross profit	164	179	204	233	239	248	267	265	257	271	285	298	313	400	513
Research and development	7	7	8	10	11	9	10	12	14	18	21	24	29	24	25
Selling, general and administrative	115	122	141	146	153	150	168	181	188	197	206	226	260	289	318
Operating income	49	57	64	88	86	98	99	83	69	75	79	72	53	110	194
Interest expense	31	31	30	15	17	17	14	14	15	14	13	19	23	37	46
Net interest income	—	36	−30	−14	−17	−15	−12	−12	−13	−13	−12	−15	—	—	—
Income before tax	13	18	6	79	77	81	88	72	56	66	72	54	11	68	137
Income tax	6	−7	9	18	−6	16	23	17	22	12	23	21	9	20	38
Net income	7	25	−3	60	83	65	65	55	34	54	49	33	2	48	100
Diluted EPS	$0.23	$0.82	−$0.10	$1.51	$2.07	$1.61	$1.61	$1.35	$0.83	$1.34	$1.21	$0.81	$0.06	$1.19	$2.43
Diluted shares (average)	—	—	32m	40m	—	—	—	—	41m	41m	41m	41m	41m	41m	41m
EBITDA	67	76	85	109	109	124	126	111	102	107	112	106	89	156	246

US$ millions unless shown otherwise. Fiscal quarters.

Phibro Animal Health Corp: income statement, quarterly
Quarter	2025 Q1Sept 2024	2025 Q2Dec 2024	2025 Q3Mar 2025	2025 Q4Jun 2025	2026 Q1Sept 2025	2026 Q2Dec 2025	2026 Q3Mar 2026	2026 Q4Jun 2026
Revenue	260	309	348	379	364	374	384	397
Cost of revenue	177	207	243	269	244	241	258	262
Gross profit	83	102	105	110	120	133	126	134
Selling, general and administrative	66	76	71	76	69	82	81	86
Operating income	18	26	34	34	51	50	45	48
Interest expense	9	10	10	9	13	12	11	11
Income before tax	10	5	30	24	36	36	32	32
Income tax	3	2	9	7	10	9	8	11
Net income	7	3	21	17	27	27	24	22
Diluted EPS	$0.17	$0.08	$0.51	$0.43	$0.65	$0.67	$0.59	$0.53
EBITDA	27	37	46	46	64	63	57	62

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: LNTH vs PAHC INDV vs PAHC PAHC vs TRLV

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Phibro Animal Health Corp's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Phibro Animal Health Corp.